Cardiometabolic risk factors at baseline and postintervention for control (N=17) and intervention (N=23) participants†
| Baseline | Postintervention | Mean difference‡ (95% CI) | Within-group p value | Between-group p value (post) | |
|---|---|---|---|---|---|
| Weight (lbs) | 0.58 | ||||
| Control | 201.4 (30.2) | 202.4 (30.5) | +1.0 (−1.0 to 3.0) | 0.31 | |
| Intervention | 194.2 (34.9) | 194.4 (34.5) | +0.2 (−2.3 to 2.7) | 0.86 | |
| BMI (kg/m2) | 0.76 | ||||
| Control | 33.2 (4.5) | 33.4 (4.6) | +0.2 (−0.1 to 0.5) | 0.21 | |
| Intervention | 31.8 (5.0) | 31.9 (5.0) | −0.1 (−0.3 to 0.5) | 0.57 | |
| Systolic BP (mm Hg) | 0.70 | ||||
| Control | 117.1 (13.0) | 117.5 (12.8) | −0.8 (−5.0 to 3.6) | 0.71 | |
| Intervention | 120.0 (13.8) | 115.7 (10.8) | −4.3 (−8.0 to −0.7) | 0.02* | |
| Diastolic BP (mm Hg) | 0.51 | ||||
| Control | 72.8 (10.3) | 73.2 (10.6) | −0.1 (−5.0 to 4.8) | 0.96 | |
| Intervention | 78.2 (10.3) | 75.4 (7.4) | −2.8 (−6.2 to 0.7) | 0.11 | |
| Waist circumference (cm) | 0.03** | ||||
| Control | 92.9 (11.1) | 93.9 (10.8) | +1.0 (−0.7 to 2.7) | 0.22 | |
| Intervention | 92.6 (11.2) | 91.6 (11.3) | −1.0 (−2.1 to 0.3) | 0.06 | |
| Estimated V02 (mL/kg/min) | 0.10 | ||||
| Control | 29.6 (2.5) | 30.0 (2.6) | +0.3 (-0.1 to 0.8) | 0.14 | |
| Intervention | 30.8 (5.1) | 31.1 (4.6) | +0.3 (-0.6 to 1.1) | 0.53 | |
| Total cholesterol (mg/dL) | 0.83 | ||||
| Control | 184.4 (25.9) | 185.0 (18.9) | −0.8 (−15.1 to 13.4) | 0.91 | |
| Intervention | 191.4 (26.3) | 189.7 (27.0) | +0.7 (−5.9 to 7.2) | 0.83 | |
| HDL (mg/dL) | 0.65 | ||||
| Control | 47.6 (18.4) | 46.7 (18.9) | −0.9 (−6.8 to 5.1) | 0.76 | |
| Intervention | 45.7 (17.6) | 43.7 (16.4) | −2.1 (−8.1 to 3.4) | 0.46 | |
| LDL (mg/dL) | 0.96 | ||||
| Control | 111.2 (32.1) | 120.2 (25.3) | +5.4 (−11.3 to 22.1) | 0.50 | |
| Intervention | 119.4 (23.2) | 116.7 (29.4) | −3.7 (−12.8 to 5.4) | 0.41 | |
| Triglycerides | 0.91 | ||||
| Control | 130.6 (65.4) | 131.0 (59.9) | +4.7 (−24.0 to 33.3) | 0.73 | |
| Intervention | 98.4 (45.2) | 118.4 (57.3) | +18.3 (−0.1 to 36.7) | 0.05 | |
*p<0.05 for within-group change from baseline (paired t test).
**p<0.05 for between-group differences at post-intervention (ANCOVA).
†Data presented as the mean (SD).
‡Mean change from baseline (95% CI), adjusted for baseline value (ANCOVA).
ANCOVA, analysis of covariance; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein.